YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer

Wenyi Mi, Haipeng Guan, Jie Lyu, Dan Zhao, Yuanxin Xi, Shiming Jiang, Forest H. Andrews, Xiaolu Wang, Mihai Gagea, Hong Wen, Làszlò Tora, Sharon Dent, Tatiana G. Kutateladze, Wei Li, Haitao Li, Xiaobing ShiNature Communications 2017 · DOI

TL;DR

This study identifies YEATS2 as a critical "reader" protein that binds to acetylated histone H3 (specifically H3K27ac) and is frequently amplified in non-small cell lung cancer (NSCLC). By binding to H3K27ac, YEATS2 helps recruit the ATAC complex to promoters of essential genes, thereby maintaining their expression and promoting cancer cell growth and survival. Disrupting this interaction hinders cancer progression, suggesting YEATS2 as a potential therapeutic target.

What Problem Does This Paper Address?

Histone modifications, like acetylation, are crucial for regulating gene expression and play a significant role in both normal development and diseases like cancer. "Reader" proteins are key players in this process, recognizing these modifications and translating them into cellular signals. While the bromodomain was long considered the primary acetyllysine reader, recent research has identified other modules. The YEATS domain, in particular, was recently identified as an acetyllysine-binding module, but its functional importance in human cancer remained largely unexplored. This paper addresses the question of whether YEATS domain-containing proteins, specifically YEATS2, play a role in cancer, and if so, how they contribute to tumorigenesis.

Methods

The researchers employed a multi-faceted approach:

  • Genomic Analysis: They analyzed The Cancer Genome Atlas (TCGA) database to identify genes amplified in human cancers, focusing on YEATS2.
  • Molecular Biology Techniques:
    • Western Blotting: Used to assess protein expression levels of YEATS2, components of the ATAC complex (GCN5, PCAF, HDAC1), and various histone acetylation marks (H3K9ac, H3K14ac, H3K27ac) in cancer cell lines and normal cells.
  • RNA Interference (RNAi): Employed shRNAs to knock down YEATS2 expression in cancer cell lines to study its functional impact.
  • Cell Proliferation and Viability Assays: Included cell counting, clonogenic assays (colony formation in soft agar), and soft agar colony formation assays to evaluate the role of YEATS2 in cancer cell growth, survival, and anchorage-independent growth.
  • RNA Sequencing (RNA-seq): Performed to identify genes whose expression is regulated by YEATS2.
  • Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Analysis: Used to interpret the biological pathways affected by YEATS2 knockdown.
  • Histone Peptide Pulldown Assays: Utilized to determine the binding specificity of the YEATS domain of YEATS2 to various acetylated histone peptides.
  • Isothermal Titration Calorimetry (ITC): Quantified the binding affinity of the YEATS domain to acetylated histone peptides.
  • X-ray Crystallography: Determined the co-crystal structure of the YEATS domain of YEATS2 bound to an H3K27ac peptide to elucidate the molecular basis of recognition.
  • Chromatin Immunoprecipitation followed by Sequencing (ChIP-seq): Used to map the genome-wide distribution of the ATAC complex (represented by ZZZ3), H3K27ac, and H3K9ac in both control and YEATS2-depleted cells.
  • Quantitative RT-PCR (qRT-PCR): Validated RNA-seq and ChIP-seq findings.
  • In vivo Xenograft Assays: Assessed the role of YEATS2 in tumor growth in mice.

Datasets

  • The Cancer Genome Atlas (TCGA) database: Used for analyzing YEATS2 gene amplification and expression status across various human cancers.
  • GEO database (GSE90781): Contains the ChIP-seq and RNA-seq data generated in this study.
  • Protein Data Bank (PDB accession code 5XNV): Stores the crystal structure data of the YEATS2-H3K27ac complex.

Key Insights and Ideas

  • YEATS2 as a Cancer Driver: The study reveals that YEATS2 is not just present but actively amplified and essential for the growth and survival of NSCLC cells, highlighting its role as a potential oncogene.
  • Specific H3K27ac Recognition: Unlike other YEATS domains that might recognize broader acetylation patterns, YEATS2 exhibits a specific preference for H3K27ac, suggesting a targeted role in gene regulation.
  • Bridging Histone Modification and Gene Expression: YEATS2 acts as a crucial link, translating the H3K27ac signal into downstream effects on gene expression, particularly for essential ribosomal protein genes.
  • ATAC Complex Recruitment: The YEATS domain's ability to bind H3K27ac is proposed to be a key mechanism for recruiting the ATAC complex to specific genomic loci, thereby influencing chromatin accessibility and transcription.
  • Ribosome Biogenesis as a Target: The significant downregulation of ribosomal protein genes upon YEATS2 depletion points to a critical role in regulating protein synthesis, a process vital for rapidly dividing cancer cells.

Key Results

  • YEATS2 Amplification in NSCLC: YEATS2 is highly amplified in various human cancers, including NSCLC (56% amplification frequency), and its expression correlates with worse prognosis.
  • YEATS2 Depletion Impairs Cancer Cell Growth: Knockdown of YEATS2 significantly reduces proliferation, survival, and anchorage-independent growth of NSCLC cells.
  • YEATS2 Binds H3K27ac: In vitro and in vivo experiments demonstrate that the YEATS domain of YEATS2 specifically binds to acetylated histone H3K27.
  • ATAC Complex Co-localization: The ATAC complex, represented by ZZZ3, co-localizes with H3K27ac and H3K9ac marks at the promoters of actively transcribed genes.
  • YEATS2 Essential for H3K9ac Maintenance: Depletion of YEATS2 leads to a reduction in global H3K9ac levels and, more specifically, on the promoters of ZZZ3-occupied genes, including ribosomal protein genes.
  • Ribosomal Protein Gene Downregulation: RNA-seq analysis revealed that 49 out of 79 known ribosomal protein genes were downregulated upon YEATS2 knockdown.
  • Structural Basis of H3K27ac Recognition: The crystal structure revealed how the YEATS domain forms an aromatic sandwich cage to recognize H3K27ac, with specific residues playing critical roles.
  • YEATS Domain Mutants Fail to Rescue Function: Mutating key residues in the YEATS domain that are involved in H3K27ac binding (Y262A, W282A) abrogated YEATS2's ability to restore H3K9ac levels, gene expression, and tumor growth in rescue experiments.

Limitations and Future Work

  • Enhancer Occupancy Variation: The study observed limited ATAC complex enhancer occupancy in NSCLC H1299 cells, contrasting with findings in other cell types. The authors suggest this might be context-dependent and influenced by other reader modules.
  • Other Acylations: While the study focuses on acetylation, the authors note that other histone acylations (crotonylation, etc.) are also associated with active transcription. They mention that they failed to detect H3K27crotonylation ChIP-seq signals, suggesting it may be present at low abundance in H1299 cells. Future work could explore the role of YEATS2 in recognizing these other modifications.
  • Therapeutic Target Potential: The findings strongly suggest YEATS2 as a potential therapeutic target for NSCLC. Further research could focus on developing specific inhibitors of YEATS2's H3K27ac binding or its role in ATAC complex recruitment.
  • Interaction with Myc: Given Myc's known role in regulating ribosomal protein genes, future studies could investigate whether the ATAC complex, through YEATS2, directly interacts with Myc or cooperates with the SAGA complex in regulating protein synthesis machinery.

Summary updated

Abstract

Recognition of modified histones by "reader" proteins constitutes a key mechanism regulating diverse chromatin-associated processes important for normal and neoplastic development. We recently identified the YEATS domain as a novel acetyllysine-binding module; however, the functional importance of YEATS domain-containing proteins in human cancer remains largely unknown. Here, we show that the YEATS2 gene is highly amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell growth and survival. YEATS2 binds to acetylated histone H3 via its YEATS domain. The YEATS2-containing ATAC complex co-localizes with H3K27 acetylation (H3K27ac) on the promoters of actively transcribed genes. Depletion of YEATS2 or disruption of the interaction between its YEATS domain and acetylated histones reduces the ATAC complex-dependent promoter H3K9ac levels and deactivates the expression of essential genes. Taken together, our study identifies YEATS2 as a histone H3K27ac reader that regulates a transcriptional program essential for NSCLC tumorigenesis.
BibTeX
@inproceedings{mi2017yeats,
  author = {Wenyi Mi and Haipeng Guan and Jie Lyu and Dan Zhao and Yuanxin Xi and Shiming Jiang and Forest H. Andrews and Xiaolu Wang and Mihai Gagea and Hong Wen and Làszlò Tora and Sharon Dent and Tatiana G. Kutateladze and Wei Li and Haitao Li and Xiaobing Shi},
  title = {{YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer}},
  booktitle = {Nature Communications},
  year = {2017},
  doi = {10.1038/s41467-017-01173-4},
}
Figure